Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623626 | SCV000741641 | pathogenic | Inborn genetic diseases | 2023-08-16 | criteria provided, single submitter | clinical testing | The c.181delC (p.L61Wfs*80) alteration, located in exon 1 (coding exon 1) of the CDK13 gene, consists of a deletion of one nucleotide at position 181, causing a translational frameshift with a predicted alternate stop codon after 80 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been determined to be the result of a de novo mutation in one individual with features consistent with CDK13-related neurodevelopmental disorder (Lee, 2020). Based on the available evidence, this alteration is classified as pathogenic. |
Undiagnosed Diseases Network, |
RCV000791281 | SCV000930573 | likely pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2019-03-07 | criteria provided, single submitter | clinical testing |